Indication
Quadramet is indicated for the relief of bone pain in patients with multiple painful osteoblastic skeletal metastases which take up technetium [99mTc]-labelled biphosphonates on bone scan. The presence of osteoblastic metastases which take up technetium [99mTc]-labelled biphosphonates should be confirmed prior to therapy.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- QuadrametCanada · 50 MCI / ML · Liquid · Superna Life Sciences IncorporatedSame brand
- Quadramet, Solucion InyectableSpain · 1,3 GIGABECQUERELIOS · solución inyectable · Cis Bio InternationalSame brand
- QuadrametCroatiaSame brand
- QUADRAMET, oplossing voor injectie 1,3 GBq/mlNetherlands · Oplossing voor injectie · Cis Bio International